Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Sarb99on Jan 14, 2021 1:06pm
192 Views
Post# 32297721

East Hampton Covid-19 Test Site Debuts to High Demand

East Hampton Covid-19 Test Site Debuts to High DemandA new drive-through coronavirus test site opened Jan. 6 at East Hampton Town Hall to meet growing demand amid a surge in Covid-19 cases nationwide, including on the East End — and residents turned out in force.
 
The website for residents to make an appointment, testbeforeyougo.com, proved spotty on the first day, when 125 people showed up to get tested, town officials said, noting that opening a Montauk location is under consideration.
 
“There’s quite a bit of demand townwide,” East Hampton Town Supervisor Peter Van Scoyoc told the Jan. 7 board meeting. “The number of cases in the town are much higher than they were during the initial outbreak.”
 
Covid-19 cases have tripled since October to nearly 900 as of last week, the supervisor said. The number of cases across Suffolk County recently doubled in a two-month period to more than 100,000.
 
COVID-19 PCR (RNA) nasal swab testing, rapid antigen testing for active viral infection diagnosis, and antibody blood testing to determine if someone has had a previous case of the virus will be available at East Hampton Town Hall from 7 a.m. to 9 p.m., seven days per week.
 
The cost will be $179 for the PCR nasal swab test, $99 for the rapid antigen test and $59 for the antibody test, all of which is covered by insurance. A limited number of free tests will be made available to those in financial need, the town said.
 
The testing will be conducted by Collection Sites, LLC, a wholly-owned subsidiary of QuestCap Inc.
 
https://www.danspapers.com/2021/01/east-hampton-covid-19-test-site-debuts-to-high-demand/
<< Previous
Bullboard Posts
Next >>